Literature DB >> 1716485

Induction of in vitro human lymphocyte migration by interleukin 3, interleukin 4, and interleukin 6.

K Bacon1, A Gearing, R Camp.   

Abstract

The effects of interleukin 3 (IL 3), IL 4, IL 6, and interferon-gamma (IFN-gamma) on lymphocyte migration have been investigated and compared with those of transforming growth factor-beta 1 (TGF-beta 1), granulocyte colony stimulating factor (GCSF), and macrophage colony stimulating factor (MCSF). Potent, temperature-dependent stimulation of lymphocyte migration was obtained in response to IL 3 and IL 4 (ED50 less than 10(-11) M and less than 10(-13) M, respectively) and this migration was abolished in the presence of 3 micrograms ml-1 cytochalasin B. IL 6 and IFN-gamma were less active (ED50 greater than or equal to 10(-9) M and greater than or equal to 10(-8) M, respectively), maximal migration in response to IFN-gamma being only 30% above background as compared with approximately 250% for IL 3 and IL 4. TGF-beta 1, GCSF, and MCSF failed to stimulate lymphocyte migration in doses similar to those used for IL 3, IL 4, and IL 6. The presence of antisera to IL 3, IL 4, and IL 6 specifically inhibited lymphocyte migration induced by the corresponding cytokines (IC50 values being 1/10,000, greater than 1/30,000, and greater than 1/30,000 dilution of antibody, respectively). Cross-desensitization experiments using IL 3 and IL 4 demonstrated that neither IL 3 nor IL 4 were able to stimulate dose-related lymphocyte migration in cells preincubated with IL 3. Cells preincubated with IL 4 were only stimulated by a supraoptimal concentration of IL 4 (10(-11) M). The induction of lymphocyte migration by IL 3, IL 4, and IL 6 therefore appears to be a specific and potentially important effect of these cytokines. Cross-desensitization of lymphocytes by IL 3 and IL 4 raises the possibility that the induction of lymphocyte migration by these cytokines may occur through a common postreceptor signal transduction mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1716485     DOI: 10.1016/1043-4666(90)90003-c

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Staphylococcal enterotoxin B-specific adhesion of murine splenic T cells to a human endothelial cell line.

Authors:  M Kita; K Eguchi; Y Kawabe; T Tsukada; K Migita; A Kawakami; N Matsuoka; S Nagataki
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

2.  Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.

Authors:  Elena Y Senchenkova; Janice Russell; Alper Yildirim; D Neil Granger; Felicity N E Gavins
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

3.  Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease.

Authors:  Valter Lubrano; Franca Cocci; Debora Battaglia; Angela Papa; Paolo Marraccini; Gian Carlo Zucchelli
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

4.  Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli.

Authors:  B Kreft; S Bohnet; O Carstensen; J Hacker; R Marre
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.

Authors:  D H Adams; L Harvath; D P Bottaro; R Interrante; G Catalano; Y Tanaka; A Strain; S G Hubscher; S Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Cytokine profiles of cultured microvascular endothelial cells from the human intestine.

Authors:  E M Nilsen; F E Johansen; F L Jahnsen; K E Lundin; T Scholz; P Brandtzaeg; G Haraldsen
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

Review 7.  IL-6 in diabetes and cardiovascular complications.

Authors:  Dan Qu; Jian Liu; Chi Wai Lau; Yu Huang
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 8.  Mast cell tissue heterogeneity and specificity of immune cell recruitment.

Authors:  Peter W West; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

9.  TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts.

Authors:  Gong Je Seong; Samin Hong; Sun-Ah Jung; Jung-Jin Lee; Eunhae Lim; Sung-Joo Kim; Joon H Lee
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

10.  Cytokine release from alveolar macrophages exposed to ambient particulate matter: heterogeneity in relation to size, city and season.

Authors:  Ragna B Hetland; Flemming R Cassee; Marit Låg; Magne Refsnes; Erik Dybing; Per E Schwarze
Journal:  Part Fibre Toxicol       Date:  2005-08-17       Impact factor: 9.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.